13:209-15.
8. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral
arterial disease in the United States: results from the National Health

and Nutrition Examination Survey, 1999-2000. Circulation
2004;110:738-43.
9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FG. Inter-Society Consensus for the Management of Peripheral
Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
10. Mahoney EM, Wang K, Keo HH, Duval S, Smolderen KG,
Cohen DJ, et al. Vascular hospitalization rates and costs in patients
with peripheral artery disease in the United States. Circ Cardiovasc
Qual Outcomes 2010;3:642-51.
11. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG,
Creager MA, Olin JW, et al. Peripheral arterial disease detection,
awareness, and treatment in primary care. JAMA 2001;286:1317-24.
12. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV,
Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and
symptomatic peripheral arterial disease in the general population. Int J
Epidemiol 1991;20:384-92.
13. Dawber TR, Kannel WB, Revotskie N, Stokes J 3rd, Kagan A,
Gordon T. Some factors associated with the development of coronary heart disease: six yearsâ€™ follow-up experience in the Framingham
study. Am J Public Health Nations Health 1959;49:1349-56.
14. Smith SC Jr, Milani RV, Arnett DK, Crouse JR 3rd, McDermott MM,
Ridker PM, et al. Atherosclerotic Vascular Disease Conference: Writing
Group II: risk factors. Circulation